MK-0616
Clinical Trial Grant
Awarded By
Merck Sharp & Dohme LLC.
Start Date
March 26, 2024
End Date
January 31, 2030
Awarded By
Merck Sharp & Dohme LLC.
Start Date
March 26, 2024
End Date
January 31, 2030